You are here
Four NIDCD Smell Grantees Receive Awards for Highly Innovative and High Impact Research
Four researchers who have received funding from the NIDCD were selected by the National Institutes of Health (NIH) as recipients of either the 2009 NIH Director's Pioneer Award or New Innovator Award. Both programs are part of the NIH Roadmap for Medical Research, established in 2004, and support exceptionally creative scientists who take highly innovative, potentially high-impact approaches to major challenges in biomedical or behavioral research. This year marks the largest number of Pioneer and New Innovator awards in the program’s history.
Timothy E. Holy, Ph.D., of the Washington University School of Medicine in St. Louis, and Gene E. Robinson, Ph.D., of the University of Illinois at Urbana-Champaign and a member of the National Academy of Sciences, are Pioneer awardees. They will receive up to $2.5 million each in direct costs over 5 years.
Stavros Lomvardas, Ph.D., of the University of California in San Francisco, and Mark W. Albers, M.D., Ph.D.,of Massachusetts General Hospital, are New Innovator awardees. They will receive up to $1.5 million each in direct costs over 5 years. This year’s awardees receive funds from the American Recovery and Reinvestment Act.
Timothy E. Holy, Ph.D.
Gene E. Robinson, Ph.D.
Stavros Lomvardas, Ph.D.
Mark W. Albers, M.D., Ph.D.